Research study Program year 2023 Source: CMS Open Payments

Nintedanib PF ILD

Research payments

$1,881,174

106 payments

Through program year 2023, $1,881,174 in research payments was reported against Nintedanib PF ILD, across 106 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..

Paid by: Boehringer Ingelheim Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$97,825	1
2022	Research	$40,483	1
2021	Research	$16,804	7
2020	Research	$425,439	22
2019	Research	$1,300,623	75

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $1,881,174 106 payments

Who received the money Research payments · program years 2019–2023

Mayo Clinic Organisation paid for research $180,166 5 payments
Uc Davis Medical Center Teaching hospital · CA $177,314 3 payments
The University Of Texas Health Science Organisation paid for research $82,242 1 payment
Inova Healthcare Services Organisation paid for research $79,814 1 payment
Duke University Organisation paid for research $76,330 4 payments
The Trustees Of Columbia University Organisation paid for research $66,872 1 payment
Baylor Research Institute Organisation paid for research $59,701 2 payments
ICAHN School of Medicine at Mount Sinai Organisation paid for research $52,635 2 payments
Pennsylvania State University College Of Medicine Organisation paid for research $49,185 2 payments
The Trustees Of Columbia University In Organisation paid for research $48,915 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.